1. Bouillon, R, Marcocci, C, Carmeliet, G, et al. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr Rev 2019; 40: 1109–1151.
Google Scholar | Crossref | Medline2. Christakos, S, Dhawan, P, Verstuyf, A, et al. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev 2016; 96: 365–408.
Google Scholar | Crossref | Medline3. Charoenngam, N, Shirvani, A, Holick, MF. Vitamin D for skeletal and non-skeletal health: What we should know. J Clin Orthopaed Trauma 2019; 10: 1082–1093.
Google Scholar | Crossref | Medline4. Wacker, M, Holick, MF. Sunlight and vitamin D. Dermatoendocrinol 2013; 5: 51–108.
Google Scholar | Crossref | Medline5. Bikle, DD . Extraskeletal actions of vitamin D. Ann N Y Acad Sci 2016; 1376: 29–52.
Google Scholar | Crossref | Medline6. Deluca, HF, Cantorna, MT. Vitamin D: its role and uses in immunology1. Faseb J 2001; 15: 2579–2585.
Google Scholar | Crossref | Medline | ISI7. Haas, J . [Vigantol--Adolf Windaus and the history of vitamin D]. Wurzbg Medizinhist Mitt 2007; 26: 144–181.
Google Scholar | Medline8. Veldman, CM, Cantorna, MT, DeLuca, HF. Expression of 1,25-Dihydroxyvitamin D3 Receptor in the Immune System. Arch Biochem Biophys 2000; 374: 334–338.
Google Scholar | Crossref | Medline | ISI9. Liu, PT, Stenger, S, Li, H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770–1773.
Google Scholar | Crossref | Medline | ISI10. Badenhoop, K, Kahles, H, Penna-Martinez, M. Vitamin D, immune tolerance, and prevention of type 1 diabetes. Curr Diab Rep 2012; 12: 635–642.
Google Scholar | Crossref | Medline11. Cyprian, F, Lefkou, E, Varoudi, K, et al. Immunomodulatory effects of vitamin D in pregnancy and beyond. Front Immunol 2019; 10: 2739.
Google Scholar | Crossref | Medline12. Adorini, L, Penna, G. Induction of tolerogenic dendritic cells by vitamin D receptor agonists. Handb Exp Pharmacol 2009; 188: 251–273.
Google Scholar | Crossref13. Illescas-Montes, R., Melguizo-Rodríguez, L, Ruiz, C, et al. Vitamin D and autoimmune diseases. Life Sci 2019; 233: 116744.
Google Scholar | Crossref | Medline14. Czaja, AJ, Montano-Loza, AJ. Evolving role of vitamin D in immune-mediated disease and its implications in autoimmune hepatitis. Dig Dis Sci 2019; 64: 324–344.
Google Scholar | Crossref | Medline15. Song, GG, Bae, SC, Lee, YH. Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis. Clin Rheumatol 2012; 31: 1733–1739.
Google Scholar | Crossref | Medline16. Cutolo, M, Otsa, K, Uprus, M, et al. Vitamin D in rheumatoid arthritis. Autoimmun Rev 2007; 7: 59–64.
Google Scholar | Crossref | Medline | ISI17. Kostoglou-Athanassiou, I, Athanassiou, P, Lyraki, A, et al. Vitamin D and rheumatoid arthritis. Ther Adv Endocrinol Metab 2012; 3: 181–187.
Google Scholar | SAGE Journals18. Hong, Q, Xu, J, Xu, S, et al. Associations between serum 25-hydroxyvitamin D and disease activity, inflammatory cytokines and bone loss in patients with rheumatoid arthritis. Rheumatology 2014; 53: 1994–2001.
Google Scholar | Crossref | Medline19. VanAmerongen, BM, Dijkstra, CD, Lips, P, et al. Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr 2004; 58: 1095–1109.
Google Scholar | Crossref | Medline | ISI20. Kragt, J, van Amerongen, B, Killestein, J, et al. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler J 2009; 15(1): 9–15.
Google Scholar | SAGE Journals | ISI21. Cantorna, MT, Hayes, CE, DeLuca, HF. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci 1996; 93: 7861–7864.
Google Scholar | Crossref | Medline | ISI22. Pierrot-Deseilligny, C, Souberbielle, JC. Widespread vitamin D insufficiency: a new challenge for primary prevention, with particular reference to multiple sclerosis. La Presse Médicale 2011; 40: 349–356.
Google Scholar | Crossref | Medline | ISI23. Mark, BL, Carson, JAS. Vitamin D and autoimmune disease-implications for practice from the multiple sclerosis literature. J Am Diet Assoc 2006; 106: 418–424.
Google Scholar | Crossref | Medline24. Littorin, B, Blom, P, Schölin, A, et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006; 49: 2847–2852.
Google Scholar | Crossref | Medline | ISI25. Greer, RM, Portelli, SL, Hung, BSM, et al. Serum vitamin D levels are lower in Australian children and adolescents with type 1 diabetes than in children without diabetes. Pediatr Diabetes 2013; 14: 31–41.
Google Scholar | Crossref | Medline26. Zipitis, CS, Akobeng, AK. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 2008; 93: 512–517.
Google Scholar | Crossref | Medline | ISI27. Yell, J, Wojnarowska, F. Diagnosis and management of systemic lupus erythematosus. Sun protection is vital. BMJ 1993; 307(6909): 939.
Google Scholar | Crossref | Medline28. Aharon-Maor, A, Shoenfeld, Y. [The role of ultraviolet light, and sun and fluorescent light, in the pathogenesis of systemic lupus erythematosus]. Harefuah 1998; 135: 295–299.
Google Scholar | Medline29. Guan, SY, Cai, HY, Wang, P, et al. Association between circulating 25‐hydroxyvitamin D and systemic lupus erythematosus: a systematic review and meta‐analysis. Int J Rheum Dis 2019; 22: 1803–1813.
Google Scholar | Crossref | Medline30. Amital, H, Szekanecz, Z, Szücs, G, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?: Table 1. Ann Rheum Dis 2010; 69: 1155–1157.
Google Scholar | Crossref | Medline | ISI31. Watad, A, Neumann, SG, Soriano, A, et al. Vitamin D and Systemic Lupus Erythematosus: Myth or Reality? Isr Med Assoc J 2016; 18: 177–182.
Google Scholar | Medline32. Aringer, M, Costenbader, K, Daikh, D, et al. 2019 European league against rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 2019; 78: 1151–1159.
Google Scholar | Crossref | Medline33. Gladman, DD, Ibañez, D, Urowitz, MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29: 288–291.
Google Scholar | Medline | ISI34. Romero-Diaz, J, Isenberg, D, Ramsey-Goldman, R. Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI). Arthritis Care Research 2011; 63(Suppl 11): S37–S46.
Google Scholar | Medline | ISI35. Shahin, D, El-Farahaty, RM, Houssen, ME, et al. Serum 25-OH vitamin D level in treatment-naïve systemic lupus erythematosus patients: Relation to disease activity, IL-23 and IL-17. Lupus 2017; 26: 917–926.
Google Scholar | SAGE Journals | ISI36. Mok, CC, Birmingham, DJ, Leung, HW, et al. Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology 2012; 51: 644–652.
Google Scholar | Crossref | Medline | ISI37. Yao, HH, Tang, SM, Wang, ZM, et al. [Study of bone mineral density and serum bone turnover markers in newly diagnosed systemic lupus erythematosus patients]. Beijing da Xue Xue Bao Yi Xue Ban 2018; 50: 998–1003.
Google Scholar | Medline38. Kamen, DL, Cooper, GS, Bouali, H, et al. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006; 5: 114–117.
Google Scholar | Crossref | Medline | ISI39. Bogaczewicz, J, Sysa-Jedrzejowska, A, Arkuszewska, C, et al. Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters. Lupus 2012; 21: 477–484.
Google Scholar | SAGE Journals | ISI40. Bae, SC, Lee, YH. Association between Vitamin D level and/or deficiency, and systemic lupus erythematosus: a meta-analysis. Cell Mol Biol 2018; 64: 7–13.
Google Scholar | Crossref | Medline41. Islam, MA, Khandker, SS, Alam, SS, et al. Vitamin D status in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis. Autoimmun Rev 2019; 18: 102392.
Google Scholar | Crossref | Medline42. Sarkar, MK, Hile, GA, Tsoi, LC, et al. Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa. Ann Rheum Dis 2018; 77: 1653–1664.
Google Scholar | Crossref | Medline43. Ahluwalia, J, Marsch, A. Photosensitivity and photoprotection in patients with lupus erythematosus. Lupus 2019; 28: 697–702.
Google Scholar | SAGE Journals | ISI44. Klein, RG, Arnaud, SB, Gallagher, JC, et al. Intestinal calcium absorption in exogenous hypercortisonism. J Clin Invest 1977; 60: 253–259.
Google Scholar | Crossref | Medline | ISI45. O'Leary, TJ, Jones, G, Yip, A, et al. The effects of chloroquine on serum 1,25-dihydroxyvitamin D and calcium metabolism in sarcoidosis. New Engl J Med 1986; 315: 727–730.
Google Scholar | Crossref | Medline | ISI46. Julkunen, H, Ekblom-Kullberg, S, Miettinen, A. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4. Rheumatol Int 2012; 32: 2445–2451.
Google Scholar | Crossref | Medline | ISI47. Abediazar, S, Jafari-Nakhjavani, M, Ghorbanihaghjo, A, et al. Serum levels of CXCL10 and vitamin D in patients with lupus nephritis. Iran J Kidney Dis 2019; 13: 389–397.
Google Scholar | Medline48. Sun, J, Zhang, S, Liu, JS, et al. Expression of vitamin D receptor in renal tissue of lupus nephritis and its association with renal injury activity. Lupus 2019; 28: 290–294.
Google Scholar | SAGE Journals | ISI49. Jin, J, Ye, M, Zhao, L, et al. The novel involvement of podocyte autophagic activity in the pathogenesis of lupus nephritis. Histol Histopathol 2018; 33: 803–814.